Amanote Research
Register
Sign In
FoxO3a Gene Is a Target of Deletion in Mouse Lung Adenocarcinoma
Oncology Reports
- Greece
doi 10.3892/or_00000507
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Date
August 31, 2009
Authors
Unknown
Publisher
Spandidos Publications
Related search
CFHR1 Is a Potentially Downregulated Gene in Lung Adenocarcinoma
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Decreased Expression of the FOXO3a Gene Is Associated With Poor Prognosis in Primary Gastric Adenocarcinoma Patients
PLoS ONE
Multidisciplinary
ASAP3 Is a Downstream Target of HIF-1α and Is Critical for Progression of Lung Adenocarcinoma
OncoTargets and Therapy
Oncology
Pharmacology
ARL4C Is Associated With Initiation and Progression of Lung Adenocarcinoma and Represents a Therapeutic Target
Cancer Science
Cancer Research
Medicine
Oncology
Matrix Metalloproteinase 11 as a Potential Therapeutic Target in Lung Adenocarcinoma
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
The Transcription Factor FOXO3a Is a Crucial Cellular Target of Gefitinib (Iressa) in Breast Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Sirt3 Is a Tumor Suppressor in Lung Adenocarcinoma Cells
Oncology Reports
Medicine
Cancer Research
Oncology
A2A Adenosine Receptor Deletion Is Protective in a Mouse Model of Tauopathy
Molecular Psychiatry
Psychiatry
Molecular Neuroscience
Mental Health
Molecular Biology
Cellular
2394 Sodium-Glucose Transporter 2 Is a Novel Diagnostic and Therapeutic Target for Early-Stage Lung Adenocarcinoma
Journal of Clinical and Translational Science
Medicine